News
Second-quarter earnings season is in full swing, and the results have been largely resilient so far. So why are stocks ...
Walt Disney posted better-than-expected results for April through June and raised its full-year earnings guidance on ...
Earnings jumped to $1.03 a share, up from $0.60 a year ago, as Emerson ( NYSE: EMR) improved its pretax margin by 570 basis ...
Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...
This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...
Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.
22hon MSN
Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...
Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...
Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).
2h
Zacks.com on MSNArbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue EstimatesArbutus (ABUS) delivered earnings and revenue surprises of +150.00% and +496.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...
The company put up a bottom-line revenue that not only exceeded Wall Street expectations, but also its own history of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results